vida: research 2026 04 29 #6037

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 15:18:39 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 15:32 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 15:32 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, drawing on specific data points and reports cited in the inbox files, such as the MSSP savings figures and GLP-1 coverage changes.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is contained within the research-journal.md file and references distinct inbox sources.
  3. Confidence calibration — The confidence calibration for Belief 3 being "STRENGTHENED" is appropriate given the quantitative evidence presented from MSSP data, and the precision added regarding market competition mechanisms is well-supported by the cited limitations.
  4. Wiki links — There are no wiki links present in the research-journal.md file to evaluate.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, drawing on specific data points and reports cited in the inbox files, such as the MSSP savings figures and GLP-1 coverage changes. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is contained within the `research-journal.md` file and references distinct inbox sources. 3. **Confidence calibration** — The confidence calibration for Belief 3 being "STRENGTHENED" is appropriate given the quantitative evidence presented from MSSP data, and the precision added regarding market competition mechanisms is well-supported by the cited limitations. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to evaluate. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR.

  2. Duplicate/redundancy — The PR adds a new research journal session synthesizing multiple sources into a single narrative entry rather than creating individual claims, so there are no duplicate claim enrichments to evaluate (all new evidence remains in source files awaiting future claim creation).

  3. Confidence — No claims are being modified or created in this PR (only sources added and journal updated), so there are no confidence levels to evaluate.

  4. Wiki links — The research journal references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims without providing wiki links, but these are narrative journal entries rather than formal claims, so missing links are appropriate for this content type.

  5. Source quality — The sources cited include CMS MSSP official reports, Health Affairs peer-reviewed analysis, MHPAEA statutory reports, and industry expert commentary (9amHealth/Waltz), all of which are credible primary or expert sources for healthcare policy and market analysis.

  6. Specificity — No new claims are being created in this PR; the research journal entry makes specific falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") but these remain in journal format awaiting formal claim extraction.

Overall Assessment

This PR adds source materials and updates Vida's research journal with a synthesis of market competition vs. structural reform evidence. No claims are being modified, so the primary risk vectors (confidence miscalibration, title overclaims, factual discrepancies in claim files) don't apply. The journal entry makes strong empirical assertions that will need proper claim extraction in future PRs, but the current PR is limited to documentation and source ingestion. The sources appear credible and the narrative synthesis is internally consistent with the evidence presented.

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR. 2. **Duplicate/redundancy** — The PR adds a new research journal session synthesizing multiple sources into a single narrative entry rather than creating individual claims, so there are no duplicate claim enrichments to evaluate (all new evidence remains in source files awaiting future claim creation). 3. **Confidence** — No claims are being modified or created in this PR (only sources added and journal updated), so there are no confidence levels to evaluate. 4. **Wiki links** — The research journal references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims without providing [[wiki links]], but these are narrative journal entries rather than formal claims, so missing links are appropriate for this content type. 5. **Source quality** — The sources cited include CMS MSSP official reports, Health Affairs peer-reviewed analysis, MHPAEA statutory reports, and industry expert commentary (9amHealth/Waltz), all of which are credible primary or expert sources for healthcare policy and market analysis. 6. **Specificity** — No new claims are being created in this PR; the research journal entry makes specific falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") but these remain in journal format awaiting formal claim extraction. ## Overall Assessment This PR adds source materials and updates Vida's research journal with a synthesis of market competition vs. structural reform evidence. No claims are being modified, so the primary risk vectors (confidence miscalibration, title overclaims, factual discrepancies in claim files) don't apply. The journal entry makes strong empirical assertions that will need proper claim extraction in future PRs, but the current PR is limited to documentation and source ingestion. The sources appear credible and the narrative synthesis is internally consistent with the evidence presented. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 15:33:11 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 15:33:11 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 16:19:12 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.